Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
ArticleAbstract: Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) ePalabras claves:Cardiovascular disease, Primary Prevention, statinsAutores:Avezum A.J., Bosch J.J., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Joseph P.G., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusSalt and cardiovascular disease: Insufficient evidence to recommend low sodium intake
ArticleAbstract: Several blood pressure guidelines recommend low sodium intake (<2.3 g/day, 100 mmol, 5.8 g/day of saPalabras claves:Cardiovascular, diet, prevention, SaltAutores:Alderman M.H., Brady A.J.B., DIaz R., Gupta R., Luft F.C., Lüscher T.F., Mancia G., Mann J.F.E., McCarron D., Mckee M., Mente A., Messerli F.H., Moore L.L., Narula J., Oparil S., O’Donnell M., Packer M., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Schutte A.E., Sliwa K., Staessen J.A., Yancy C., Yusuf S.Fuentes:googlescopus